Research Groups and R&D Platforms: Biomarker

Research Group:
Drug Discovery and Diagnostics tools and detection methods

Harri Härmä
harri.harma[at]utu.fi

Analytical Chemistry,
University of Turku

Harri Härmä

Antibodies, Assay development, Biomarker, Biomedicine, Biomolecular chemistry, Biotechnology, Clinical Chemistry, Diagnostics, Drug target, Fluorescence spectroscopy, FTIR or RAMAN microscopy, FTIR or RAMAN spectroscopy, In Vitro Diagnostics, Molecular diagnostics, Nanoparticles, Next-generation sequencing, Nucleic acids, Particle size analysis, Pattern recognition, Personalized medicine, Receptor, Screening, Signaling, Thermal analysis

Research Group:
Functional Biomaterials & Microfluids

Hongbo Zhang
hongbo.zhang[at]abo.fi

Pharmaceutical Sciences Laboratory,
Åbo Akademi University

Hongbo Zhang

Structural Bioinformatics Laboratory

Precision Nanomedicine and Diagnostics

Atomic-force microscopy, Bioinformatics, Biomarker, Biomedicine, Cancer, Cardiovascular diseases, Data mining, Drug delivery, Drug solubility, Drug stability, Drug target, Electron microscopy, Fluorescence spectroscopy, FTIR or RAMAN spectroscopy, Genetics, Genomics, High throughput imaging, Imaging, Imaging software, In Vivo Diagnostics, Lead optimization, Molecular diagnostics, Nanoparticles, Next-generation sequencing, NMR, Nucleic acids, Organic compounds, Particle morphology, Particle size analysis, Personalized medicine, PET, Physico-chemical properties, Polymorph analysis, Porosity, Screening, Super-resolution imaging, Surface area, Synthetic chemistry, Target discovery, Thermal analysis, Ultrasound imaging, X-ray crystallography, Zeta potential

Research Group:
New tools to target harmful inflammations and cancer

Sirpa Jalkanen
sirjal[at]utu.fi

Institute of Biomedicine,
University of Turku

Sirpa Jalkanen

Cell Trafficking in Cancer and Inflammation

Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery

Research Group:
RNA regulation in male germ cells

Noora Kotaja
nookot[at]utu.fi

Institute of Biomedicine,
University of Turku

Noora Kotaja

Basic research, Biomarker, Biomedicine, Cancer, Data mining, Developmental disorders, Disease models, Electron microscopy, Endocrinology, Epigenomics, Genomics, Imaging, Imaging software, Metabolic diseases, Molecular Biology, Molecular Cell Biology, Next-generation sequencing, Personalized medicine, Proteomics, Reproductive Medicine, Screening, Super-resolution imaging, Target discovery

Research Group:
Prognostic features in triple-negative breast carcinoma

Pauliina Kronqvist
paukro[at]utu.fi

Institute of Biomedicine,
University of Turku

Pauliina Kronqvist

Biomarker, Breast cancer, Cancer, Data mining, Diagnostics, Genomics, Imaging, Molecular diagnostics, Next-generation sequencing, Pathology, Personalized medicine, Point of care

Research Group:
Early nutrition and health

Kirsi Laitinen
kirsi.laitinen[at]utu.fi

Institute of Biomedicine,
University of Turku

Kirsi Laitinen

Early Nutrition and Health

Allergy, Biomarker, Diabetes, Inflammation, Metabolic diseases, Natural products, Nutrition, Obesity